Study to Assess the Efficacy and Safety of Ublituximab and Umbralisib in Subjects With Chronic Lymphocytic Leukemia (CLL) Currently Treated With Ibrutinib or Venetoclax
出处
期刊：Case medical research [Case Journals] 日期：2019-07-11
标识
DOI：10.31525/ct1-nct04016805
摘要
Study to Assess the Efficacy and Safety of Ublituximab and Umbralisib in Subjects With Chronic Lymphocytic Leukemia (CLL) Currently Treated With Ibrutinib, Acalabrutinib or Venetoclax - Full Text View.
PDF的下载单位、IP信息已删除
(2025-6-4)
Kao
大力的冬萱
v0id
cdercder
yjh123
ale
OK
张欢馨
十三
prigogin
Avalonx
行走的荷尔蒙
热心的粉红小企鹅
arniu2008
aaaa
lx
明亮尔蓝
sagitar
Oracle
丰富语蕊
皖公网安备34019202002308
